MXCT
Maxcyte·NASDAQ
--
--(--)
--
--(--)
4.24 / 10
Netural
Analyst sentiment is neutral, with a consensus Hold rating from five firms (one Sell, two Hold, two Buy). The weighted rating of 0.69 aligns with the current falling price trend. Fund-flow analysis, however, shows strength: an overall score of 7.78/10 with positive Extra-large and block inflows, despite negative Small and Medium trends. This liquidity support may mitigate downside pressure in the short term. The juxtaposition of cautious analyst views and robust fund inflows creates a balanced yet uncertain outlook—supportive enough to prevent a free-fall but not compelling enough to initiate aggressive buying.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-07-22
InstitutionStephens & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for MXCT?
- MXCT holds a Bearish analyst rating, with 33% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.24/10 (Netural).
